CERVICAL CANCER SCREENING PROGRAMME

Reporting year for qualitative data:	2025
Source of qualitative data:	Directly from Programme

Organization of screening
An individual/team/institution responsible to coordinate the programme:	Yes
Dedicated budget for screening programme:	Yes
Documented cancer screening policy:	Yes
Nature of documentation of the policy:	Notification
Year programme was initiated:	2019
Programme introduction was preceded by a pilot:	Yes, pilot evaluated and report published
Screening tests provided free of charge:	Yes
Diagnostic tests provided free of charge:	Yes
Treatment services provided free of charge:	Yes
Information system and data collection
System that collects data:	Aggregated
• Identification of eligible population:	-
• Screening participation:	Aggregated
• Screening test results:	Aggregated
• Further assessment:	Aggregated
• Final pathology diagnosis:	Aggregated
• Cancer staging:	Aggregated
• Treatment:	Aggregated
The information system exists at national or sub-national level:	Individual: Unknown Aggregated: Sub-national
The information system collects data outside the programme (opportunistic screening/private sector):	No
Cancer screening data is linked with population-based cancer registry (PBCR):	No
Screening protocol
A screening protocol or guideline:	Yes
Year of published/updated protocol:	2023
Target age (min-max) and screening interval [months] for each test:	HPV (25-65 years / [60 months])
Triaging test used:	VIA
Self-collection HPV recommended:	No
"Screen and treat" included in the protocol:	Yes
Treatment modality for "screen and treat":	Thermal ablation LLETZ/CKC
Invitations for screening and further assessment
Initiatives to create population awareness by the Health Ministry/Health Authority:	Mass media campaign Small media campaign Group education One-on-one education Dedicated website Social media platform
Invitations to eligible population:	Yes
Source of the eligible individuals identified:	List from GP or PHC Other
Method of invitation:	Home visits by health workers
Screening kit included with the invitation:	Yes
Screen positive individuals actively contacted for further assessment:	Yes
Individuals with a precancer or cancer diagnosis actively contacted:	Yes
Quality Assurance (QA) of screening activities
Documented standard operating procedure/policy for QA:	No
An individual/team/institution responsible for QA:	No
Accreditation of lab services:	Yes
Accreditation of pathology services:	-
Documented performance indicators:	Yes
Reference standards for performance indicators:	No
Evaluation reports published in the last five years:	Yes
Performance indicators
Reporting year for quantitative data:	No data currently available

Check also the following factsheets: Benin, Breast, Colorectal